The emergence of antimicrobial-resistant bacterial infections has changed the recommendations for the empirical therapy of community- and hospital-acquired meningitis. In the United States, approximately 34% of pneumococcal isolates are penicillin nonsusceptible, and approximately 14% are resistant to ceftriaxone.1 More than 50% of nosocomial infections in patients in the intensive care unit are due to methicillin-resistant Staphylococcus aureus.2,3 The first documented case of vancomycin-resistant S aureus was reported in the United States in 2002. 4.
ASJC Scopus subject areas
- Arts and Humanities (miscellaneous)
- Clinical Neurology